Crossref journal-article
Oxford University Press (OUP)
International Immunology (286)
Bibliography

Traber, K. E., Okamoto, H., Kurono, C., Baba, M., Saliou, C., Soji, T., Packer, L., & Okamoto, T. (1999). Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-α-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. International Immunology, 11(2), 143–150.

Authors 8
  1. Katrina E. Traber (first)
  2. Hiroshi Okamoto (additional)
  3. Chieko Kurono (additional)
  4. Masanori Baba (additional)
  5. Claude Saliou (additional)
  6. Tsuyoshi Soji (additional)
  7. Lester Packer (additional)
  8. Takashi Okamoto (additional)
References 37 Referenced 34
  1. Baeuerle, P. A. and Baichwal, V. R. 1997. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol.65:111. (10.1016/S0065-2776(08)60742-7)
  2. Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol.14:649. (10.1146/annurev.immunol.14.1.649)
  3. Thanos, D. and Maniatis, T. 1995. NF-κB: a lesson in family values. Cell80:529. (10.1016/0092-8674(95)90506-5)
  4. Okamoto, T., Sakurada, S., Yang, J.-P. and Merin, J. P. 1997. Regulation of NF-κB and disease control: identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-κB activation. Curr. Topics Cell. Reg.35:149. (10.1016/S0070-2137(97)80006-4)
  5. Hayashi, T., Ueno, Y. and Okamoto, T. 1993. Oxidoreductive regulation of nuclear factor kappa B. J. Biol. Chem.268:11380. (10.1016/S0021-9258(18)82135-4)
  6. Okamoto, T., Josephs, S. F., Sadaie, M. R. and Wong-Staal, F. 1990. Transcriptional activation from the long-terminal repeat of human immunodeficiency virus in vitro. Virology177:606. (10.1016/0042-6822(90)90526-W)
  7. Baeuerle, P. A. and Baltimore, D. 1988. I-kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science242:540. (10.1126/science.3140380)
  8. Ghosh, S. and Baltimore, D. 1990. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I-kappa B. Nature344:678. (10.1038/344678a0)
  9. Arya, S. R., Guo, C., Josephs, S. F. and Wong-Staal, F. 1985. Trans-activator gene of human lymphotropic virus type III (HTLVIII). Science229:74. (10.1126/science.2990040)
  10. Okamoto, T. and Wong-Staal, F. 1986. Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system. Cell47:29. (10.1016/0092-8674(86)90363-6)
  11. Okamoto, T., Matsuyama, T., Mori, S., Manamoto, Y., Kobayashi, N., Yamamoto, N., Josephs, S. F., Wong-Staal, F. and Shimotohno, K. 1989. Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha. AIDS Res. Hum Retroviruses5:131. (10.1089/aid.1989.5.131)
  12. Bohnlein, E., Lowenthal, J. W., Siekevitz, M., Ballard, D. W., Franza, B. R. and Greene, W. C. 1988. The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell53:827. (10.1016/0092-8674(88)90099-2)
  13. Madhok, R., Crilly, A., Murphy, E., Smith, J., Watson, J. and Capell, H. A, 1993. Gold therapy lowers serum interleukin levels in rheumatoid arthritis. J. Rheumatol.20:630.
  14. Crilly, A., Madhok, R., Watson, J., Capell, H. A. and Sturrock, R. D. 1994. Production of interleukin-6 by monocytes isolated from rheumatoid arthritis patients receiving second-line drug therapy. Br. J. Rheumatol.33:821. (10.1093/rheumatology/33.9.821)
  15. Yanni, G., Nabil, M., Farahat, M. R., Poston, R. N. and Panayi, G. S. 1994. Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann. Rheum. Dis.53:315. (10.1136/ard.53.5.315)
  16. Loetscher, P., Dewald, B., Baggiolini, M. and Seitz, M. 1994. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. Cytokine6:162. (10.1016/1043-4666(94)90038-8)
  17. Seitz, M, Dewald, B., Ceska, M., Gerber, N. and Baggiolini, M. 1992. Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol. Int.12:159. (10.1007/BF00274936)
  18. Yoshida, S., Kato, T., Sakurada, S., Kurono, C., Yang, J.-P., Matsui, N., Soji, T. and Okamoto, T. 1999. Inhibition of IL-6 and IL-8 induction from primary rheumatoid synovial fibroblasts by treatment with aurothioglucose. Int. Immunol.11:151. (10.1093/intimm/11.2.151)
  19. Williams, D. H., Jeffery, L. J. and Murray, E. J. 1992. Aurothioglucose inhibits induced NF-κB and AP-1 activity by acting as an IL-1 functional antagonist. Biochim. Biophys. Acta1180:9. (10.1016/0925-4439(92)90020-N)
  20. Yang, J.-P., Merin, J. P., Nakano, T., Kato, T., Kitade, S. and Okamoto, T. 1995. Inhibition of the DNA-binding activity of NF-κB by gold compounds in vitro. FEBS Lett.361:89. (10.1016/0014-5793(95)00157-5)
  21. Butera, S. T., Rerez, V. L., Wu, B.-Y., Nabel, G. J. and Folks, T. M. 1991. Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of activation in a CD4+ cell model of chronic infection. J. Virol.65:4645. (10.1128/JVI.65.9.4645-4653.1991)
  22. Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H. and Fauci, A. S. 1986. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl Acad. Sci. USA86:2365. (10.1073/pnas.86.7.2365)
  23. Luo, Y., Madore, S. J., Parslow, T. G., Cullen, B. R. and Peterlin, B. M. 1993. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus 1 in cells. J. Virol.67:5617. (10.1128/JVI.67.9.5617-5622.1993)
  24. Okamoto, T., Ogiwara, H., Hayashi, T., Mitsui, A., Kawabe, T. and Yodoi, J. 1992. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Int. Immunol.4:811. (10.1093/intimm/4.7.811)
  25. Vandeputte, C., Guizon, I., Genestie-Denis, I., Vannier, B. and Lorenzon, G. 1994. A microtiter plate assay for total glutathione and glutathione disulfide contents in cultures/isolated cells: performance study of a new miniaturized protocol. Cell Biol. Toxicol.10:415. (10.1007/BF00755791)
  26. Gallagher, E., Kavanagh, T. and Eaton, D. 1994. Glutathione, oxidized glutathione and mixed disulfides in biological samples. Methods Toxicol.1B:349. (10.1016/B978-0-08-092440-3.50035-X)
  27. Okamoto, K. and Utamura, M. 1938. Biologische untersuchungen des Goldes. 1 Mitteilung uber die histochemische Gold nachweis-methode. Acta Scholae. Med. Kioto.22:373.
  28. Luft, J. 1961. Improvement in epoxy resin embedding methods. J. Biophys. Biochem. Cytol.9:409. (10.1083/jcb.9.2.409)
  29. Mascarenhas, B., Granda, J. and Freyberg, R. 1972. Gold metabolism in patients with rheumatoid arthritis treated with gold compounds—reinvestigated. Arthritis Rheum.15:391. (10.1002/art.1780150410)
  30. Merin, J. P., Matsuyama, M., Kira, T., Baba, M. and Okamoto, T. 1996. Alpha-lipoic acid blocks HIV-1 LTR-dependent expression of hygromycin resistance in THP-1 stable transformants. FEBS Lett.394:9. (10.1016/0014-5793(96)00919-2)
  31. Shapiro, D. L. and Masci, J. R. 1996. Treatment of HIV associated psoriatic arthritis with oral gold. J. Rheumatol.23:1818.
  32. Jacque, J. M., Fernandez, B., Arenzana-Seisdedos, F., Thomas, D,. Baleux, F., Virelizier, J. L. and Bachelerie, F. 1996. Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kB is needed for persistent viral replication in monocytes. J. Virol.70:2930. (10.1128/JVI.70.5.2930-2938.1996)
  33. Sato, T., Asamitsu, K., Yang, J.-P., Takahashi, N., Tetsuka, T., Yoneyama, A., Kanagawa, A. and Okamoto, T. 1998. Inhibition of HIV-1 replication by fasudil hydrochloride. AIDS Res. Hum. Retroviruses14:293. (10.1089/aid.1998.14.293)
  34. Vint, I. A., Foreman, J. C. and Chain, B. M. 1994. The gold anti-rheumatic drug auranofin governs T cell activation by enhancing oxygen free radical production. Eur. J. Immunol.24:1961. (10.1002/eji.1830240904)
  35. Tozawa, K., Sakurada, S., Kohri, K. and Okamoto, T. 1995. Effects of anti-nuclear factor κB reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res.55:4162.
  36. Sakurada, S., Kato, T. and Okamoto,T. 1996. Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-l-cysteine and aspirin. Int. Immunol.8:1483. (10.1093/intimm/8.10.1483)
  37. Zabel, U., Schreck, R. and Baeuerle, P. A. 1991. DNA binding of purified transcription factor NF-kappa B: Affinity, specificity, Zn2+ dependence, and differential half-site recognition. J. Biol. Chem.266:252.
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 6:22 p.m.)
Deposited 4 years, 3 months ago (May 17, 2021, 11:54 a.m.)
Indexed 2 weeks ago (Aug. 23, 2025, 12:59 a.m.)
Issued 26 years, 7 months ago (Feb. 1, 1999)
Published 26 years, 7 months ago (Feb. 1, 1999)
Published Online 26 years, 7 months ago (Feb. 1, 1999)
Published Print 26 years, 7 months ago (Feb. 1, 1999)
Funders 0

None

@article{Traber_1999, title={Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-α-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells}, volume={11}, ISSN={0953-8178}, url={http://dx.doi.org/10.1093/intimm/11.2.143}, DOI={10.1093/intimm/11.2.143}, number={2}, journal={International Immunology}, publisher={Oxford University Press (OUP)}, author={Traber, Katrina E. and Okamoto, Hiroshi and Kurono, Chieko and Baba, Masanori and Saliou, Claude and Soji, Tsuyoshi and Packer, Lester and Okamoto, Takashi}, year={1999}, month=feb, pages={143–150} }